Attovia Therapeutics, Inc. (ATTO)

Attovia Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Attovia Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	1.35	1.35	-
Gross Profit	1.35	1.35	-
Selling, General & Admin	-	14.36	7.69
Research & Development	-	54.15	33.86
Operating Expenses	-	68.51	41.55
Operating Income	-71.01	-67.16	-41.55
Interest Expense (Income)	-6.83	-6.63	-3.44
Other Expense (Income)	-0.05	0.1	1.69
Pretax Income	-64.13	-60.9	-45.05
Net Income	-64.13	-60.63	-39.8
Net Income Common	-64.13	-60.9	-45.05
Free Cash Flow	-64.02	-61.51	-36.81
Gross Margin	100.00%	100.00%	-
Operating Margin	-5260.00%	-4974.74%	-
Profit Margin	-4750.52%	-4510.96%	-
Free Cash Flow Margin	-4742.07%	-4556.44%	-
EBITDA	-70.06	-66.45	-42.93
EBITDA Margin	-5189.33%	-4922.22%	-
Depreciation & Amortization	0.9	0.8	0.31
EBIT	-70.96	-67.25	-43.24
EBIT Margin	-5256.22%	-4981.78%	-